BioNTech (BNTX) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
BioNTech (BNTX) quarterly earnings & revenue
BioNTech (BNTX) reported revenue of $139.73M for Q1 2026, down 34.3% year-over-year, with net income of $-629.33M and diluted EPS of $-2.49.
Over the last four reported quarters, BioNTech generated $3.26B in revenue and $-1.46B in net income.
BioNTech's next earnings report is scheduled for August 4, 2026 before market open; analysts estimate EPS of $-2.40.
BioNTech quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q1 2026 | $139.73M | -34.3% | $-629.33M | $-2.49 |
| Q4 2025 | $1.05B | -24.5% | $-351.70M | $-1.43 |
| Q3 2025 | $1.77B | +22.0% | $-33.41M | $-0.14 |
| Q2 2025 | $303.58M | +102.6% | $-450.02M | $-1.86 |
| Q1 2025 | $212.79M | -2.6% | $-484.01M | $-2.01 |
| Q4 2024 | $1.39B | -19.5% | $302.07M | $1.26 |
| Q3 2024 | $1.45B | +39.0% | $230.60M | $0.94 |
| Q2 2024 | $149.81M | -23.3% | $-940.31M | $-3.98 |
BioNTech (BNTX) — frequently asked questions
When does BioNTech (BNTX) report earnings next?
BioNTech is expected to report earnings on August 4, 2026 before market open. Analysts estimate EPS of $-2.40.
What was BNTX's revenue last quarter?
BioNTech reported revenue of $139.73M in Q1 2026, down 34.3% from the same quarter a year earlier.
What was BNTX's EPS last quarter?
BioNTech reported diluted EPS of $-2.49 in Q1 2026.
Is BioNTech profitable?
BioNTech is currently not profitable, with $-1.46B in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Roche (ROG.SW) · Merck (MRK)